Papers/PMID:19821418
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.
The Cochrane database of systematic reviews2009The record
2 findings · 1 compound · 2 endpoints
What it reported
How to read these marksWhat moved
2 findings
coenzyme Q10 — decreases systolic blood pressure (setting unspecified)
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Findingreplicated ×1“Treatment with coenzyme Q10 in subjects with systolic BP (SBP) > 140 mmHg or diastolic BP (DBP) > 90 mmHg resulted in mean decreases in SBP of 11 mmHg (95% CI 8, 14) and DBP of 7 mmHg (95% CI 5, 8).”
Quoted verbatim from Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.. - Study
- meta-analysis
- Population
- adults with primary hypertension (SBP >140 mmHg or DBP >90 mmHg); Cochrane meta-analysis of 3 RCTs, 96 participants, coenzyme Q10 versus placebo for at least 3 weeks
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.2009PMID:19821418Permalink
coenzyme Q10 — decreases diastolic blood pressure (setting unspecified)
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Finding“Treatment with coenzyme Q10 in subjects with systolic BP (SBP) > 140 mmHg or diastolic BP (DBP) > 90 mmHg resulted in mean decreases in SBP of 11 mmHg (95% CI 8, 14) and DBP of 7 mmHg (95% CI 5, 8).”
Quoted verbatim from Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.. - Study
- meta-analysis
- Population
- adults with primary hypertension (SBP >140 mmHg or DBP >90 mmHg); Cochrane meta-analysis of 3 RCTs, 96 participants, coenzyme Q10 versus placebo for at least 3 weeks
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.2009PMID:19821418Permalink